A historically-controlled Phase III study in adults to characterize the acceptability of a process change for manufacturing inactivated quadrivalent influenza vaccine

BACKGROUND: An inactivated quadrivalent influenza vaccine (QIV) was recently licenced in the US as a thimerosal-free formulation presented in a pre-filled syringe. A multidose presentation is preferred in some settings due to reduced acquisition and cold storage costs. We assessed the immunogenicity...

詳細記述

保存先:
書誌詳細
主要な著者: Jain, Varsha K, Chandrasekaran, Vijayalakshmi, Wang, Long, Li, Ping, Liu, Aixue, Innis, Bruce L
フォーマット: Artigo
言語:Inglês
出版事項: BioMed Central 2014
主題:
Research Article
オンライン･アクセス:https://ncbi.nlm.nih.gov/pmc/articles/PMC3995899/
https://ncbi.nlm.nih.gov/pubmed/24606983
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1471-2334-14-133
タグ: タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!

類似資料